GGI
ALT icon

Godsey & Gibb Inc’s Altimmune ALT Stock Holding History

Godsey & Gibb Inc’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-611
Closed -$6.87K – 388
2023
Q4 		$6.87K Hold
611
– – ﹤0.01% 290
2023
Q3 		$1.59K Hold
611
– – ﹤0.01% 312
2023
Q2 		$2.16K Hold
611
– – ﹤0.01% 333
2023
Q1 		$2.58K Hold
611
– – ﹤0.01% 297
2022
Q4 		$10.1K Hold
611
– – ﹤0.01% 205
2022
Q3 		$8K Hold
611
– – 0.01% 49
2022
Q2 		$7K Buy
+611
New +$3.77K ﹤0.01% 77
2022
Q1 		– Sell
-611
Closed -$6K – 104
2021
Q4 		$6K Hold
611
– – ﹤0.01% 89
2021
Q3 		$7K Hold
611
– – ﹤0.01% 75
2021
Q2 		$6K Buy
+611
New +$8.36K ﹤0.01% 79

Other funds holding ALT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Godsey & Gibb Inc's ALT Position: Q1 2024 in Review

Godsey & Gibb Inc sold out of Altimmune (ALT) in Q1 2024, closing a stake of 611 shares — an estimated $6.87K sold.

Godsey & Gibb Inc first reported a position in ALT in Q2 2021 and held it in 10 quarters. The position peaked at $10.1K in Q4 2022. 172 funds tracked by Wall St. Rank hold ALT as of Q1 2024.

  • Godsey & Gibb Inc reported no remaining Altimmune position as of Q1 2024 after selling out during the quarter.
  • Godsey & Gibb Inc sold 611 Altimmune shares in Q1 2024, an estimated $6.87K.
  • Godsey & Gibb Inc first reported a position in Altimmune in Q2 2021 and held it in 10 quarters.
  • Godsey & Gibb Inc's Altimmune position peaked at $10.1K in Q4 2022.
  • 172 funds tracked by Wall St. Rank held Altimmune as of Q1 2024.

Based on Godsey & Gibb Inc's 13F filing for Q1 2024, filed 23 Apr 2024.